The New York State Department of Financial Services, the Bitlicense regulator, has authorized GMO to issue stablecoins-linked in US dollars and Japanese yen. The latter “will be the first of its kind available to the public”. To date, the regulator has issued 27 charters and licenses for companies engaged in crypto business.

First Regulated Yen Stablecoin Approved in NY

The New York State Department of Financial Services (DFS) has granted a charter under New York banking law to Trust Company Inc., a subsidiary of Japanese giant GMO Internet. This allows the company to operate as a limited liability trust company, the regulator announced Tuesday, elaborating on:

With DFS approval, GMO is authorized to issue, manage and exchange Japanese yen and US dollar-linked stablecoins in New York. The Japanese yen stablecoin will be the first of its kind available to the public.

“Including the charter granted to GMO, DFS has to date approved 27 charters and licenses for companies engaged in virtual currency business activities,” the announcement continues.

GMO-z Trust Company President Ken Nakamura commented, “We are breaking new ground with our move to issue the first regulated JPY-linked stablecoin, which many see as a safe haven. But we are also pioneers and innovators in this space looking to build new applications of blockchain technology that transform our relationship with traditional financial services. “

The DFS began licensing companies dealing with cryptocurrency businesses in 2015 and has since been revise her crypto regulatory approach. “This includes streamlining the process for businesses to adopt new coins through a self-certification framework and coin greenlist, using the department’s conditional licensing authority, and providing new clarity about DFS processes and expectations to applicants and licensed entities, ”the regulator described.

Do you think GMOs are regulated? yen stablecoin will be popular in the US? Let us know in the comments below.

Image Credits: Shutterstock, Pixabay, Wiki Commons

Disclaimer: This article is for informational purposes only. It is not a direct offer or invitation to an offer to buy or sell, or a recommendation or endorsement of products, services or companies. does not provide investment, tax, legal or accounting advice. Neither the company nor the author is directly or indirectly responsible for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.

Source link